F. Matthews

NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

Hongkai Ji, A. Lander, A. Calof, 2021, Nature Methods.

NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

Hongkai Ji, A. Lander, A. Calof, 2020, Nature Methods.

Somatic reversion in DOCK8 immunodeficiency modulates disease phenotype

D. Lewis, Y. Zhang, R. Geha, 2014 .